Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

Bristol Myers Squibb has continued its ruthless cost-cutting push, dropping plans to commercialize a rival to Dupixent despite meeting its phase 3 goals and pumping the brakes on a would-be ...

Read more › Aid to South Africa: Mr. Trump ordered that all aid to South Africa be halted and said his administration would prioritize the resettling of white “Afrikaner refugees” into the ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

Haiyun Jiang for The New York Times Job cuts: The Trump administration plans to retain only about 290 of the more than 10,000 employees worldwide at the U.S. Agency for International Development ...

the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.

As the Trump administration attempts to scale back the size of the federal government, the president has suggested disaster relief should be left to states and that FEMA needs to be overhauled or ...

WASHINGTON (AP) — Top Trump administration officials are openly questioning the judiciary’s authority to serve as a check on executive power as the new president’s sweeping agenda faces ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent—including agreements with payers and pharmacy benefit managers that ...

This includes Dupixent, Adbry, and Ebglyss. These medications are injected into the fatty area beneath your skin. Typically, these treatments are given every other week. You may be able to administer ...